We came across a bullish thesis on Eli Lilly and Company on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company’s share was trading at $724.54 as of September 26th. LLY’s trailing and forward P/E were 47.36 and 24.04 respectively according to Yahoo Finance.
Few companies have captured investor attention like Eli Lilly, which has emerged as the leader in the obesity treatment...
